PODD News and Press, Insulet Corporation From 04/16/25

2025-04-16 13:04:12 ET More on Abbott Laboratories, Alphatec, etc. Abbott Laboratories (ABT) Q1 2025 Earnings Call Transcript Examination Of Alphatec Holdings: Prognosis--Chronic Cash Burn Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript Abbott si...

2025-04-13 08:38:00 ET Summary Oakmark Bond Fund performed in-line with its benchmark in the first quarter of 2025 as both posted strong absolute returns. The Fund’s Institutional Share Class returned 2.66% versus 2.78% for its benchmark, the Bloomberg U.S. Aggregate Bond I...

2025-04-08 11:55:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above Canada NewsWire New Diabetes Canada Guidelines 1 recommend people with type 1 diabetes use an ...

2025-04-03 12:42:10 ET More on Boston Scientific, Stryker Boston Scientific: Bright Future, Rather Pricey Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript) Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Scie...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2025 on May 8, 2025, after the close of the financial ma...

2025-03-28 15:59:00 ET Summary Baird Small/Mid Cap Growth portfolio increased +5.1% in the fourth quarter, net of fees, compared to the +2.4% increase in our primary benchmark, the Russell 2500 Growth Index. The market moved through three distinct phases in the fourth quarter, def...

2025-03-28 13:38:00 ET Summary In 2024, we delivered results for our clients that fell far below our benchmark, and our own expectations. The overall growth rate of the portfolio slowed directly in an environment where benchmark performance called for faster growth. Equity mar...

2025-03-27 10:50:00 ET Summary Columbia Select Large Cap Growth Fund Institutional Class shares returned 4.16% in Q4 2024, trailing the Russell 1000 Growth Index's 7.07% return. U.S. stock market gained 2.75% in Q4, driven by mega-cap tech companies, particularly those benefiting ...

2025-03-23 09:05:46 ET Pfizer exits Haleon stake after $3.2B share sale More on Health Care Select Sector SPDR® Fund ETF XLV: With Relative Strength In January And Compelling Valuation, Health Care Earnings On Tap XLV: Buy Diversity And Growth SA Charts:...